Targeted treatments and immunotherapy for Haematological Cancers – November 2026
Virtual delivery via MS TeamsHaematological cancers differ from solid tumours in many ways: in the mutations that drive them, their interactions with their environment, and the treatments that are effective against them. This course introduces the biology, behaviours and genetics of this diverse group of diseases with a focus on the features we can now target and the mechanisms of action of the various treatments
Targeted treatments and immunotherapy for Lung Cancer – September 2026
Virtual delivery via MS TeamsA focus on modern systemic treatments for non-small cell lung cancer (NSCLC) as well as the gene faults that drive many NSCLCs; the targeted treatments that exploit these faults, such as inhibitors of EGFR, ALK, ROS1, B-Raf, HER2, MET, and RET; the immune system and checkpoint inhibitor group of immunotherapies, including PD-1, PD-L1 and CTLA-4 targeted antibody therapies
The 4Ps Researcher Development Programme (September – December 2026) Cohort 12
Virtual delivery via MS TeamsThe 4Ps Programme has been developed by research active healthcare professionals in Newcastle and is designed to support colleagues' needs no matter where they are on the “research interested” to “Aspiring Clinical Academic” continuum
Demystifying the Science Behind Systemic Treatments for Prostate, Bladder and Kidney Cancers – July 2026
Virtual delivery via MS TeamsDuring this introduction to the science behind a wide variety of systemic treatments given to people with prostate, bladder, or kidney cancer, Dr Elaine Vickers will discuss current hormone therapies, immunotherapy and targeted treatments.
Targeted treatments and immunotherapy for Breast Cancer
Virtual delivery via MS TeamsThis course explains why breast cancer arises, the different ways that the DNA in our cells gets damaged and the targeted treatments that match a few of the known mutations. It also explores the science behind hormone therapies, targeted therapies, and immunotherapies given to patients with hormone receptor-positive, HER2-positive, and triple-negative breast cancer.
Targeted treatments and immunotherapy for Upper GI Cancers
Virtual delivery via MS TeamsThis course provides an overview of the targeted therapies and immunotherapies given to some people with oesophageal, stomach, pancreatic or liver cancer, or cancers of the biliary system
The 4Ps Researcher Development Programme (January – May 2026) Cohort 10
Virtual delivery via MS TeamsThe 4Ps Programme has been developed by research active healthcare professionals in Newcastle and is designed to support colleagues' needs no matter where they are on the “research interested” to “Aspiring Clinical Academic” continuum
Targeted treatments and immunotherapy for Bowel Cancer
Virtual delivery via MS TeamsThis course describes how bowel cancer comes about, and explains the reasons why some patients might be given treatments such as EGFR-targeted antibodies (cetuximab and panitumumab), angiogenesis inhibitors (bevacizumab and regorafenib), or immune checkpoint inhibitors (pembrolizumab) as part of their treatment.
Introduction to the Science of Systemic Cancer Treatments and Cancer Biomarkers
Virtual delivery via MS TeamsKnowledge gained through this course will enhance learners’ understanding of cancer biology, the mechanism of action of systemic cancer treatments, and the use of biomarkers to select the best treatments for each patient and as a result empower staff to feel confident when communicating with patients and their families, and with clinical and non-clinical colleagues.
The 4Ps Researcher Development Programme (September – December 2025) Cohort 9
Virtual delivery via MS TeamsThe 4Ps Programme has been developed by research active Nurses, Midwives and Allied Health Professionals in Newcastle and is designed to support your needs no matter where you are on the “research interested” to “Aspiring Clinical Academic” continuum
The 4Ps Researcher Development Programme (April – September 2025) Cohort 8
Virtual delivery via MS TeamsThe 4Ps Programme has been developed by research active Nurses, Midwives and Allied Health Professionals in Newcastle and is designed to support your needs no matter where you are on the “research interested” to “Aspiring Clinical Academic” continuum
Targeted Treatments and Immunotherapy for Solid Tumours: Demystifying the Science – February 2025
Virtual delivery via MS TeamsThis course gives cancer nurses and trial staff the knowledge and confidence to discuss a wide range of targeted cancer treatments and immunotherapies with patients and colleagues.